Search Login Register

Buruli Ulcer Summary

Description: A lesion in the skin and subcutaneous tissues due to infections by MYCOBACTERIUM ULCERANS. It was first reported in Uganda, Africa.

Also Known As: Infections, Mycobacterium ulcerans; Infection, Mycobacterium ulcerans; Mycobacterium ulcerans Infections; Ulcer, Buruli; Mycobacterium ulcerans Infection

Networked: 159 relevant articles (11 outcomes, 11 trials/studies) for this Disease

Key Drugs and Agents for Buruli Ulcer

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Rifampin (Rifampicin) : 8 outcomes 1 study in 34 results : FDA 13 Generic
  2. Streptomycin (Streptomycin Sulfate) : 6 outcomes 2 studies in 25 results : FDA 7
  3. DNA (Deoxyribonucleic Acid) : 1 outcome 1 study in 11 results : IBA
  4. Anti-Bacterial Agents (Antibiotics) : 1 outcome in 11 results : IBA
  5. Antigens : 1 outcome in 3 results : IBA
  6. A-Form DNA (A-DNA) : 1 outcome in 1 result : IBA
  7. Heparin (Liquaemin) : 1 outcome in 1 result : FDA 74 Generic
  8. mycolactone : 3 studies in 35 results : IBA
  9. mycolactone A : 1 study in 9 results : IBA
  10. Carbon Monoxide : 1 study in 5 results : IBA
Show All >>

Diseases Related to Buruli Ulcer

  1. Buruli Ulcer
  2. Thrombosis (Thrombus)
  3. Pain (Aches)
  4. Infection
  5. Skin Diseases
Show All >>

Key Therapies for Buruli Ulcer

Efficacy Chart >>
  1. Combination Drug Therapy (Combination Chemotherapy) : 2 outcomes in 2 results
  2. Drug Therapy (Chemotherapy) : 1 outcome in 7 results
  3. Induced Hyperthermia (Thermotherapy) : 1 study in 2 results
  4. Amputation : 3 results
  5. Transplants (Transplant) : 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.